Filter By Industry
Select One Biotech Research Science
Filter By Tag
Select One ACC1 ACC2 Acetylation Acetyltransferase Assay Kit Assay Kits Biotech Bps Brd Bromodomain Cancer Cholesterol Drug Discovery Drug Screening Epigenetics EZH Hat Hcv Hdac Hep C Immunotherapy JQ1 Life Sciences Methyl Reader Methyltransferase Notch Nsd Parp PBEF PCSK9 PD-1 PD1 Pharmaceutical PHGDH Phramaceutical Proteases Rar TNKS Weaver Syndrome Wnt
BPS Bioscience, Inc. Press releases1 - 10 of 14 Press Releases
Jun 10, 2014
BPS Bioscience, Inc. (BPS) is now offering its newest cell line: the Hippo Pathway TEAD Reporter – MCF7 Cell Line.
May 29, 2014
BPS Bioscience, Inc. (“BPS”) has developed several new assay kits (BTLA:HVEM, CD28:B7-1, and CTLA4:B7-1) and related proteins to advance immunotherapy research.
Apr 23, 2014
BPS Bioscience, Inc. introduces unique EZH2 mutants and 2 new assay kits for screening EZH2 inhibitors
Oct 31, 2013
Unique Portfolio of Proteins and Assay Kits for PD-1-related Research and Drug Discovery
Oct 14, 2013
BPS Bioscience, Inc. (“BPS”) announces the addition of a panel of 6 protease enzymes for identifying small molecule inhibitors of the Hepatitis C virus (HCV). These unique enzymes are also available for custom screening and profiling services.
Sep 16, 2013
Expanding the Largest Portfolio of Proteins and Assay Kits for Epigenetic Research and Drug Discovery
Jul 15, 2013
First commercially available NSD kits for inhibitor screening and profiling applications
May 14, 2013
Expanding the Array of Tools Available for Life Science Research
Mar 28, 2013
Announcing the Availability of Methyl-Lysine Reader Proteins and Assay Kits for a New Class of Epigenetic Drug...
Mar 13, 2013
BPS Bioscience, Inc. (“BPS”) announced the addition of 3 new assay kits (BRD9, CREBBP, and TRIM24) for identifying small molecule inhibitors of bromodomains (BRDs).
RSS Feed for BPS Bioscience, Inc. Press Releases